Table 4.

Adjusted odds ratio for death and/or default outcomes among HIV-infected TB patients.

1. Those with cure, complete, death outcomes
Comparison groups versus non-reactive	All patients				Culture-confirmed TB
	n	AOR	95% CI		n	AOR	95% CI
			L	U			L	U
HBsAg +	385	1.0	0.3	3.3	188	0.5	0.1	4.9
Anti-HCV +	504	1.1	0.6	1.9	253	1.4	0.6	3.6
HBsAg and anti-HCV +	374	2.1	0.6	7.6	185	4.8	0.5	42.9
2. Those with cure, complete, death, and default outcomes
Comparison groups versus non-reactive	All patients				Culture-confirmed TB
	n	AOR	95% CI		n	AOR	95% CI
			L	U			L	U
HBsAg +	420	2.7	1.1	6.4	207	5.5	1.4	21.9
Anti-HCV +	549	1.2	0.8	2.0	281	2.0	1.0	4.0
HBsAg and anti-HCV +	401	1.4	0.4	4.7	198	1.7	0.3	11.2

+ sign indicates reactive; bold type indicates statistical significance (p < 0.05); TB, tuberculosis, HIV, human immunodeficiency virus; AOR, adjusted odds ratio; CI, confidence interval; L, lower bound; U, upper bound; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus, N, number of patients included in the model.

*Adjusted odds ratios from multivariate logistic regression analyses adjusted for TB disease severity, HIV disease severity, co-trimoxazole use, fluconazole use, anti-retroviral use, whether or not received directly observed therapy, hospitalized at enrollment and been treated for TB previously